語言選擇: 中文版 ∷  英文版
    NOW:Home > Case

    Tonghua Dongbao Pharmaceutical Group

    date:2021-04-26 10:41 hits:

    The company is mainly engaged in Chinese and Western patent medicines, 

    biological products and plastic building materials, etc. 

    It is a key high-tech enterprise of the Torch Program recognized by the Ministry of Science and Technology.

    The company and its major shareholder Dongbao Group have successively developed and launched a large number of state-level new drugs and 

    leading products such as "Zhennaoning", Dongbao Gantai Tablets, and Naoxuekang Tablets.

    The second-phase expansion project of Dongbao genetically recombinant human insulin, 

    a key national support project for the revitalization of the old industrial base in Northeast China, 

    with a total investment of 350 million yuan, is intensively introducing and installing advanced foreign equipment.

    The company has become one of the largest human insulin production bases in China.


    Copyright © 2002-2020 大連舒心宏業建材有限公司 版權所有 遼ICP備18014590號-1 遼公網安備 21021302000235號

    美女裸体被 羞羞网站免费